Home » Topics » Regulatory

Regulatory
RSS

Novartis receives approvable letter for Diovan as treatment for heart failure

Oct. 26, 2001

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Nonopioid analgesic effects reported for nitecapone and other COMT inhibitors

Oct. 25, 2001

Tipifarnib-based antitumor combinations extensively patented by Janssen

Oct. 24, 2001

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

FDA grants expedited approval for Protonix I.V. in Zollinger-Ellison syndrome Rx

Oct. 24, 2001

Gleevec submitted for FDA review in gastrointestinal tumors

Oct. 24, 2001

Approval of Xeloda for treatment of breast cancer recommended in E.U.

Oct. 23, 2001

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...